A case of Euglycemic diabetic ketoacidosis caused by dapagliflozin Hina Zahid3 Aug 2018 6:00 PM ISTDr.Chou, Yu-Mou and colleagues have reported a case of a case of Euglycemic diabetic ketoacidosis caused by dapagliflozin which has appeared in...
Exenatide+dapagliflozin good treatment option after metformin for diabetes patients Medha Baranwal Baranwal22 Aug 2018 7:20 PM ISTThe combination of exenatide once weekly (QW) plus dapagliflozin produced sustained improvements of systolic blood pressure, weight, and glycemia than...
SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns Hina Zahid31 Aug 2018 8:35 PM ISTThe Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
Diabetes medications linked to increased risk of amputation Medha Baranwal Baranwal19 Nov 2018 7:28 PM ISTType 2 diabetes (T2D) patients treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors have an increased risk of lower-limb amputation and...
EMA approves first oral add-on to insulin for type 1 diabetes Hina Zahid7 Feb 2019 7:05 PM ISTThe European Medicines Agency (EMA) has recommended extending the licence for dapagliflozin to include an indication as an adjuvant treatment with...
Dapagliflozin reduces hospitalisation rate and death risk in heart failure: DECLARE Trial Medha Baranwal Baranwal21 March 2019 7:25 PM ISTDELHI: Diabetes drug dapagliflozin offers cardiovascular benefits that extend across a wide spectrum of patients with heart failure, and also reduces...
ADA releases major updates to 2019 Standards of Medical Care in Diabetes Medha Baranwal Baranwal2 April 2019 7:00 PM ISTThe American Diabetes Association(ADA) has issued important updates to the 2019 Standards of Medical Care in Diabetes, earlier reported by Speciality...
FDA approves combination drug for better blood sugar control in Diabetes Deepanjana Sarkar10 May 2019 7:05 PM ISTFDA approves combination drug for better blood sugar control in Diabetes.The U.S Food and Administration has approved a combination drug formula...
Warning-SGLT2 Inhibitors may mask ketoacidosis preoperatively, prove fatal Hina Zahid22 July 2019 10:20 AM ISTSGLT2 Inhibitors may mask a lethal complication of diabetes namely ketoacidosis at the time of surgery and prove fatal, finds a new study.SGLT2...
Dapagliflozin receives FDA fast track designation for chronic kidney disease Medha Baranwal Baranwal29 Aug 2019 7:10 PM ISTAstraZeneca’s dapagliflozin (FARXIGA) has received FDA's Fast Track designation for chronic kidney disease (CKD). Dapagliflozin is a sodium-glucose...
Blood sugar: Early addition of SGLT2 inhibitor dapagliflozin helps achieve better goals Medha Baranwal Baranwal4 Sept 2019 9:02 AM ISTBlood sugar: Early addition of SGLT2 inhibitor dapagliflozin helps achieve better goals,according to a recent study.Early dapagliflozin use is...
Dapagliflozin is new treatment for heart failure, finds NEJM study Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:28 PM ISTHeart failure occurs when the heart is no longer able to efficiently pump blood in the body as it should. Diuretics and Ace inhibitors have been the...
